Home›Companies›Biotech & Pharma›Lumina Pharmaceuticals

Lumina Pharmaceuticals Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 20, 2025·Suggest an edit

About Lumina Pharmaceuticals

Lumina Pharmaceuticals is a private company based in Boston, Massachusetts, incorporated in 2025 in Delaware. It has reported $2,000,000 raised in one offering on Form D since June 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 7, 2025Jun 20, 2025$2,000,000fully sold2$1.0MSimple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lumina Pharmaceuticals's Form D filed Jun 20, 2025.

AS
Alma Sorensen
President and director
PC
CF
Cara Ferreira
Executive officer and director

Sources

  1. SECLumina Pharmaceuticals Inc. filing history